UK CLL Forum. Ibrutinib for relapsed/refractory chronic lymphocytic leukemia: a UK and Ireland analysis of outcomes in 315 patients. Haematologica 2016;101(12):1563-1572; https://doi.org/10.3324/haematol.2016.147900.